Lantus [insulin glargine] vs sulfonylurea as add-on therapy in type 2 diabetic patients failing metformin monotherapy: Comparison of effects on beta cell function and metabolic profile.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

10 Dec 2013 Treatment table added.
16 Jul 2012 Additional lead trial investigator (Ji Young Ahn) identified as reported by ClinicalTrials.gov.
16 Jul 2012 Actual initiation date changed from Oct 2007 to Sep 2007 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com